Spezialisierung „R“: Reduce, Refine, Replace
Arbeitsfelder: Wissenschaft, Industrie, Vertrieb
Themenkomplexe: Sicherheits- und Unbedenklichkeitsprüfung, OCED-Richtlinien, Veterinärmedizin, Biomedizin, Grundlagenforschung, Methodenentwicklung, Anwendungsorientierte Forschung, Toxikologie
Link zur Website: www.sellomics.com

While developing 3R in vitro models, researchers struggle to find primary biological materials from humans and animals for their studies. Researchers in both university and Pharma are afraid that without matching material from several body locations from the same donor/patient, they will not be able to establish suitable controls and negatively affect their ability to produce valuable data. Sellomics GmbH is a Life Science company supporting the 3R community by providing valuable primary biological material, cells and tissues from human and companion animals and by providing tools, services and reagents for cell biology, tissue engineering and drug discovery. By providing animal-derived primary cells, Sellomics supports the development of new medicaments for companion animals and supports researchers in the selection of the best animal model. This avoids the employment of animals in studies that would not lead to significant data (Reduce), allows refining procedures to minimize safety issues while gathering data in vitro (Refine) and allows to develop new models that can substitute animal studies entirely (Replace).